NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials &…
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful…
Read More...
Read More...